Comparison of next‐generation sequencing and cobas EGFR mutation test v2 in detecting EGFR mutations
Sign Up to like & getrecommendations! Published in 2022 at "Thoracic Cancer"
DOI: 10.1111/1759-7714.14685
Abstract: As the number of genetic mutations that must be tested increases, the Oncomine Dx Target test (ODxTT), which can simultaneously detect multiple cancer‐related genes is becoming the main test used in preference to single‐molecule testing.… read more here.
Keywords: detecting egfr; egfr mutation; test; mutation test ... See more keywords
Bronchial brushing cytology is comparable to bronchial biopsy for epidermal growth factor receptor mutation test in non-small cell lung cancer
Sign Up to like & getrecommendations! Published in 2020 at "CytoJournal"
DOI: 10.25259/cytojournal_73_2019
Abstract: Objectives: Bronchial brushing (BB) is often used to obtain supplementary samples for diagnosing lung cancer. We examined the possibility of epidermal growth factor receptor (EGFR) testing on BB samples and compared them with bronchial biopsy… read more here.
Keywords: biopsy; bronchial biopsy; cytology; biopsy samples ... See more keywords
Performance of Ultra-Rapid Idylla™ EGFR Mutation Test in Non-Small-Cell Lung Cancer and Its Potential at Clinical Molecular Screening
Sign Up to like & getrecommendations! Published in 2023 at "Cancers"
DOI: 10.3390/cancers15092648
Abstract: Simple Summary Genetic information is essential before starting the treatment of advanced-stage non-small-cell lung cancer (NSCLC) and in the adjuvant setting (EGFR mutation status only) after pulmonary resection of early-stage NSCLC. Several genetic tests for… read more here.
Keywords: mutation test; mutation; idylla egfr; egfr mutation ... See more keywords
Evaluation of Combined use of Fecal Multigene Mutation Test and Fecal Immunochemical Test for Colorectal Cancer Screening.
Sign Up to like & getrecommendations! Published in 2022 at "Clinical laboratory"
DOI: 10.7754/clin.lab.2022.211202
Abstract: BACKGROUND The aim was to investigate the value of concomitant use of fecal KRAS-APC-p53-BRAF mutation test and a fecal immunochemical test (FIT) for colorectal cancer (CRC) screening. METHODS Stool samples of 279 subjects were collected… read more here.
Keywords: multigene mutation; test; mutation test; mutation ... See more keywords